Showing 1 - 10 of 50
Persistent link: https://www.econbiz.de/10010458340
"Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...
Persistent link: https://www.econbiz.de/10003682093
Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...
Persistent link: https://www.econbiz.de/10012766548
Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...
Persistent link: https://www.econbiz.de/10012464790
Persistent link: https://www.econbiz.de/10011822088
The COVID-19 pandemic has forced federal, state and local policymakers to respond by legislating, enacting, and enforcing social distancing policies. However, the impact of these policies on healthcare utilization in the United States has been largely unexplored. We examine the impact of...
Persistent link: https://www.econbiz.de/10012482350
Persistent link: https://www.econbiz.de/10012415186
The COVID-19 pandemic has forced federal, state and local policymakers to respond by legislating, enacting, and enforcing social distancing policies. However, the impact of these policies on healthcare utilization in the United States has been largely unexplored. We examine the impact of...
Persistent link: https://www.econbiz.de/10013228255
Persistent link: https://www.econbiz.de/10013350386
Persistent link: https://www.econbiz.de/10003191899